source
- AstraZeneca signs up to $1.7 billion R&D pact with China’s CSPC, marking second deal in six monthsAstraZeneca announced a new research collaboration with Chinese partner CSPC, valued at up to $1.7 billion. The agreement follows a previous large biobucks deal signed less than six months earlier…
- Abiomed recalls Impella CP Sets with SmartAssist over low purge pressure riskAbiomed has issued a recall of specific Impella CP Sets with SmartAssist after discovering that the units do not meet design specifications. The defect can cause low purge pressure events from the…